According to the filing on Companies House, Mr Keen departed the company on May 18, just one week after McKesson UK announced that its CEO Toby Anderson had stepped down from his role with “immediate effect”, after almost four years in the post.
Private equity firm Aurelius Group completed the acquisition of McKesson UK last month (April 7).
A spokesperson for McKesson UK told C+D today (May 20) that Mr Keen had taken the decision to step down from the business “to take a break and explore new opportunities”.
Dominik Müser – who works within Aurelius's leadership team – will “step into the position of chief financial officer with immediate effect”, they added.
“It is vital we have a strong and stable leadership team”
In a statement, McKesson UK also told C+D that its executive leadership team would “continue to lead the business with the support of Aurelius Group”.
It is “vital” they added, “that we have a strong and stable leadership team in place to help us deliver our ambitious strategy”.
“We are confident that we have the right people in place, and we regularly review our structures to ensure we are set up for success,” they said.
Read more: Lloydspharmacy may sell substantial number of branches, sources tell C+D
The statement also reiterated that the company remains focused on delivering “great services for customers and patients” across each of its individual businesses, “as we strive to become the UK’s leading healthcare organisation”.
Echoing the sentiment shared when announcing Mr Anderson’s departure last week, they added, “through Lloydspharmacy, Lloydspharmacy Clinical Homecare and AAH, we play a vital role in protecting the health of communities across the country”.
“Now with the expertise and backing of Aurelius Group, we have an exciting opportunity to grow and improve our business even more over the next few years.”
